This review will explore proposed mechanisms of anti-CTLA-4 involving Treg inhibition and highlights novel approaches to improve the efficacy of anti-CTLA-4 therapy while reducing its toxicity in cancer treatment. This evidence concerns the gene CTLA4 and cancer.